U.S. Food & Drug Administration · September 21, 2026
Par Pharmaceutical Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 Recall: Presence of particulate
- Affected product
- Par Pharmaceutical Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400
- Category
- Drugs
- Hazard
- Presence of particulate matter identified as cellulose or stopper material
